MIR4455: A Drug Target / Disease Biomarker (G100616111)
MIR4455: A Drug Target / Disease Biomarker
MIR4455 is a protein that is expressed in various tissues of the body, including the brain, heart, and lungs. It is a member of the MIR family of proteins, which are known for their role in the regulation of cell proliferation and survival.
One of the things that makes MIR4455 so interesting as a drug target is its unique structure. MIR4455 is a protein that consists of 214 amino acids, and it has a unique shape that allows it to interact strongly with other proteins. This interaction with other proteins makes MIR4455 a good candidate for drugs that want to target specific proteins.
In addition to its unique structure, MIR4455 also has a number of unique functions. For example, it is involved in the regulation of cell adhesion, which is the process by which cells stick together to form tissues. MIR4455 is also involved in the regulation of cell survival, and it has been shown to play a role in the regulation of cell cycle progression.
Despite its many interesting functions, MIR4455 is not yet a drug target. There are a number of different approaches that could be taken in order to target MIR4455, including protein knockout, overexpression of the protein, and use of small molecules and antibodies to interact with the protein. However, the lack of human studies makes it difficult to fully understand the potential of MIR4455 as a drug target.
In conclusion, MIR4455 is a protein that is expressed in various tissues of the body and has a number of unique functions. Its unique structure and the regulation of cell adhesion and survival make it a good candidate for drugs that want to target specific proteins. Further research is needed to fully understand the potential of MIR4455 as a drug target.
Protein Name: MicroRNA 4455
The "MIR4455 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR4455 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
MIR4456 | MIR4457 | MIR4458 | MIR4458HG | MIR4463 | MIR4465 | MIR4466 | MIR4467 | MIR4468 | MIR4469 | MIR4470 | MIR4472-1 | MIR4472-2 | MIR4474 | MIR4475 | MIR4476 | MIR4478 | MIR4479 | MIR448 | MIR4481 | MIR4482 | MIR4483 | MIR4484 | MIR4485 | MIR4486 | MIR4487 | MIR4488 | MIR4489 | MIR4491 | MIR4492 | MIR4493 | MIR4496 | MIR4497 | MIR4498 | MIR4499 | MIR449A | MIR449B | MIR449C | MIR4500 | MIR4500HG | MIR4501 | MIR4504 | MIR4505 | MIR4506 | MIR4507 | MIR4508 | MIR4509-1 | MIR4509-2 | MIR4509-3 | MIR450A1 | MIR450A2 | MIR450B | MIR4510 | MIR4511 | MIR4512 | MIR4513 | MIR4514 | MIR4516 | MIR4519 | MIR451A | MIR451B | MIR452 | MIR4520-1 | MIR4520-2 | MIR4521 | MIR4524A | MIR4524B | MIR4525 | MIR4526 | MIR4527 | MIR4527HG | MIR4529 | MIR4530 | MIR4531 | MIR4533 | MIR4534 | MIR4535 | MIR4536-1 | MIR4536-2 | MIR4537 | MIR4538 | MIR4539 | MIR454 | MIR4540 | MIR455 | MIR4632 | MIR4633 | MIR4634 | MIR4635 | MIR4638 | MIR4639 | MIR4640 | MIR4641 | MIR4642 | MIR4644 | MIR4645 | MIR4646 | MIR4647 | MIR4648 | MIR4649
